Search

Your search keyword '"Gimenez-Roqueplo, Anne-Paule"' showing total 829 results

Search Constraints

Start Over You searched for: Author "Gimenez-Roqueplo, Anne-Paule" Remove constraint Author: "Gimenez-Roqueplo, Anne-Paule"
829 results on '"Gimenez-Roqueplo, Anne-Paule"'

Search Results

151. MON-212 Genetic Spectrum Of A Canadian Cohort Of Sporadic Pheochromocytomas And Paragangliomas: Higher Prevalence Of Germline Mutations In PGL And NGS Assay With A Multigene Panel Increases The Mutation Rate

152. Germline mutations in the new E1’ cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma

153. Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study

154. SDHA is a tumor suppressor gene causing paraganglioma

155. Succinate detection using in vivo 1H-MR spectroscopy identifies germline and somatic SDHx mutations in paragangliomas

156. Successful Targeting of an ATG7-RAF1 Gene Fusion in Anaplastic Pleomorphic Xanthoastrocytoma With Leptomeningeal Dissemination

158. Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2

159. Genetics of Pheochromocytoma and Paraganglioma in Spanish Patients

164. Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families

171. Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes

173. Genetic Testing in Pheochromocytoma or Functional Paraganglioma

180. Erratum: The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (Cell Reports (2018) 23(1) (313–326.e5) (S2211124718304364) (10.1016/j.celrep.2018.03.075))

181. Evolutionarily conserved susceptibility of the mitochondrial respiratory chain to SDHI pesticides and its consequence on the impact of SDHIs on human cultured cells

182. Transcriptome Analysis of lncRNAs in Pheochromocytomas and Paragangliomas

183. The Immune Landscape of Cancer

184. Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma

185. Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma

186. Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma

187. Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma

189. Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHBand SDHD

190. International initiative for a curated SDHBvariant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma

191. Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients

193. Screening of a Large Cohort of Asymptomatic SDHx Mutation Carriers in Routine Practice.

194. Fibromuscular dysplasia

195. Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients

196. Identification of a new exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease.

197. Pheochromocytomas and secreting paragangliomas

198. Germline DLST Variants Promote Epigenetic Modifications in Pheochromocytoma-Paraganglioma.

199. The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas

200. International consensus on initial screening and follow-up of asymptomatic SDHxmutation carriers

Catalog

Books, media, physical & digital resources